SCHEMBL27717138

SCHEMBL27717138

O=C(O)Cc1cc(-c2ccccc2)ccc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.53
ABCC4 O15439 1/20 0.53
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53
TSHR P16473 1/20 0.53
HTT P42858 1/20 0.53
MMP1 P03956 2/20 0.47
MMP2 P08253 2/20 0.47
MMP3 P08254 2/20 0.47
MMP9 P14780 2/20 0.47
MMP12 P39900 2/20 0.47
MMP13 P45452 2/20 0.47
MMP14 P50281 2/20 0.47
MMP8 P22894 1/20 0.47
MMP16 P51512 1/20 0.47
DCLRE1B Q9H816 2/20 0.47
DCLRE1A Q6PJP8 1/20 0.47
SUCNR1 Q9BXA5 1/20 0.47
CXCL8 P10145 2/20 0.46
AKR1B1 P15121 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19987891 0.89 MMP1 (0.50) PTGS1ABCC4LMNAGAATSHR
SCHEMBL538898 0.86 PTGS1 (0.53) PTGS1ABCC4LMNAGAATSHR
SCHEMBL5156156 0.83 PTGS1 (0.59) PTGS1ABCC4LMNAGAATSHR
SCHEMBL11724859 0.81 AKR1B1 (0.59) PTGS1ABCC4LMNAGAATSHR
SCHEMBL19512828 0.79 PTGS1 (0.61) PTGS1ABCC4LMNAGAATSHR
SCHEMBL27604738 0.79 PTGS1 (0.57) PTGS1ABCC4LMNAGAATSHR
SCHEMBL11836950 0.77 PTGS1 (0.52) PTGS1ABCC4LMNAGAATSHR
SCHEMBL1920727 0.77 PTGS1 (0.55) PTGS1ABCC4LMNAGAATSHR
SCHEMBL29471363 0.77 TSHR (0.53) TSHRMMP1MMP2MMP3MMP9
SCHEMBL503667 0.77 TSHR (0.53) TSHRMMP1MMP2MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102659774-A Piperidine and piperazine derivatives as P2X3 antagonists HOFFMANN LA ROCHE 2012-09-12 CN disclosed
CN-101282972-A Piperidine and piperazine derivatives as P2X3 antagonists HOFFMANN LA ROCHE (CH) 2008-10-08 CN disclosed